Treatment outcomes are associated with HBeAg and HBsAg reduction after 24 weeks of treatment with telbivudine in the 2410 Roadmap studyKarsten Wursthorn,Teerha Piratvisuth,Heiner Wedemeyer,Michael P. Manns, Mechthild E. Jung,Yuhong Dong,Behrend J. Zacher,Aldo TrylesinskiHEPATOLOGY(2013)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要